Neumora Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Neumora Therapeutics, Inc. reported Earnings Per Share Diluted of $1.45 (loss) per share for the year ending 2025.

  • Neumora Therapeutics, Inc. showed an increase of +5.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Neumora Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Neumora Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 69.9%.
  • Historical annual values: Fiscal year 2025: $1.45 (loss) per share | Fiscal year 2024: $1.53 (loss) per share | Fiscal year 2023: $3.63 (loss) per share | Fiscal year 2022: $4.81 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: